<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02526121</url>
  </required_header>
  <id_info>
    <org_study_id>CEICA;PI10/099</org_study_id>
    <nct_id>NCT02526121</nct_id>
  </id_info>
  <brief_title>Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia</brief_title>
  <official_title>Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Aragones de Ciencias de la Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Aragones de Ciencias de la Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of iron depletion with phlebotomies on
      blood triglyceride concentration, in subjects with hypertriglyceridemia and iron overload,
      compared with a dietary intervention alone.

      All subjects in this study will follow dietary and lifestyle counseling in a period of 3
      months.

      A randomized group will receive phlebotomies every 3 weeks in this period.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Triglycerides concentration</measure>
    <time_frame>Three months before</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Iron parameters</measure>
    <time_frame>Three months before</time_frame>
    <description>Ferritin level: &gt;300 µgr/L in men and &gt;200 µgr/L in women</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>Three months before</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>HDL-cholesterol</measure>
    <time_frame>Three months before</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>LDL- cholesterol</measure>
    <time_frame>Three months before</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Apolipoprotein A1</measure>
    <time_frame>Three months before</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Apolipoprotein B</measure>
    <time_frame>Three months before</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Peripheral Insulin resistance measured by HOMA</measure>
    <time_frame>Three months before</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Inflammatory cytokines</measure>
    <time_frame>Three months before</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>C Reactive Protein</measure>
    <time_frame>Three months before</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Hyperferritinemia</condition>
  <condition>Hypertriglyceridemia</condition>
  <arm_group>
    <arm_group_label>Phlebotomy associated with dietary and lifestyle counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary and lifestyle counseling.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phlebotomy</intervention_name>
    <description>Volume of 400 mL every 3 weeks, 3 times.</description>
    <arm_group_label>Phlebotomy associated with dietary and lifestyle counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary and lifestyle counseling.</intervention_name>
    <description>Dietary and lifestyle counseling.</description>
    <arm_group_label>Phlebotomy associated with dietary and lifestyle counseling</arm_group_label>
    <arm_group_label>Dietary and lifestyle counseling.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hyperferritinemia: &gt; 300µgr/L for male and &gt;200µgr/L for female.

          -  Hypertriglyceridemia: &gt; 200 mg/dL in two determinations after at least ten hours of
             fasting and lipid-lowering diet.

        Exclusion Criteria:

          -  Contraindications for phlebotomy: poor venous access, previous intolerance
             (hypotension or apprehension), heart disease, anemia.

          -  Subjects suffering from acute or chronic disease, including liver disease, diabetes,
             cancer, kidney disease or uncontrolled thyroid disease.

          -  Elevated C reactive protein (CRP) as a parameter of inflammation (&gt;10mg/L).

          -  Alcohol intake: over 30 gr. per day for men and 25 gr. per day for women.

          -  Lipid lowering drugs use.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando Civeira, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unidad de Lípidos/ Laboratorio de Investigación Molecular; Hospital Universitario Miguel Servet; Instituto Aragonés de Ciencias de la Salud (Zaragoza, Spain)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2015</study_first_submitted>
  <study_first_submitted_qc>August 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2015</study_first_posted>
  <last_update_submitted>August 29, 2016</last_update_submitted>
  <last_update_submitted_qc>August 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Aragones de Ciencias de la Salud</investigator_affiliation>
    <investigator_full_name>Fernando Civeira</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertriglyceridemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

